LFHP-1c is a PGAM5 inhibitor with neuroprotective activity in ischemic stroke; it protects the integrity of the blood-brain barrier against ischemic injury by binding to endothelial PGAM5, inhibiting its phosphatase activity and disrupting the interaction between PGAM5 and NRF2; it exhibits protective effects both in vitro and in vivo.